👩🏼‍🔬 Connect with your fans, peers, and stakeholders, build trust in your scientific results, and earn a living online with the only Open Source movement of its kind built for creators by creators.

While Intuitive Surgical still leads the market, there are a number of other surgical robotics companies making waves.

Like the Hugo RAS from Medtronic, Johnson & Johnson’s (Ottava). Although Medtronic’s HUGO RAS and J&J’s Ottava have a miniscule market share currently, they are poised to expand ...

UBS forecasts 19% growth, with potential to approach 25%. At 35x and 28x its 2025 and 2026 estimated earnings per share of $2.51 and $3.00, respectively, the bank sees a favorable risk-reward profile.

Go beyond Intuitive, and there’s medtech giant Medtronic, which is seeking urological indications for its Hugo robot at the FDA — and has enjoyed success with its Mazor robots for spine surgery.

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend stocks. Dividend stocks have taken a backseat in the market as technology and AI ...

What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how ...

the Hugo System, for an area that remains deeply underpenetrated. Both of these niches could represent powerful, long-term tailwinds for the company. Furthermore, Medtronic is implementing ...